Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy

NCT04174898 is registered in ClinicalTrials.gov with Landmark Medical Centre Sdn Bhd as lead sponsor.

NCT NCT04174898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04174898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Mesenchymal Stem Cell (hMSC) Infusion for Anti-Aging and REGENerative Therapy
Lead sponsor
Landmark Medical Centre Sdn Bhd
Phase
Phase 1
Overall status
Unknown status
Start date
April 15, 2020
Completion date
April 14, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging well, regenerative medicine